8.2.2024
•
News
M&A
Tax
Assisting the owners in the sale of ANESAN
KSB's team led by Drahomír Tomašuk and Ján Béreš, with the support of Jan Černohouz, provided the owners of ANESAN with comprehensive legal advice on the sale of 100% of the company. ANESAN operates a long-term acute care hospital in Český Brod, which is the oldest healthcare facility of its kind in the Czech Republic. ANESAN’s facility is located on the premises of the Český Brod hospital and has a total capacity of 15 beds and a highly specialized team of doctors and nurses. The buyer is the Penta Hospitals CZ group.
In addition to preparing the company for sale, providing due diligence on the sellers' side, and preparing and negotiating the transaction documentation, our services included corporate and tax advisory.
More information can be found here.
Other articles
1.4.2025
•
News
We Succeeded in Another International Ranking
Just a week after the results of the Chambers Europe ranking were announced, we’re thrilled to share more great news – the renowned Legal 500 has published its annual overview of the leading law firms in the EMEA region, and we have once again confirmed our strong market position.
26.3.2025
•
News
We Confirmed Our Strong Standing in the Chambers Europe Rankings
We are pleased to announce that we have confirmed last year’s strongest-ever results in the Chambers Europe rankings, published by Chambers & Partners. In the 2025 edition, KŠB once again received excellent rankings in 11 categories. In addition, 13 of our colleagues received individual recognition—our best result in the firm’s history. This year’s recognition is crowned by a nomination for the prestigious Chambers Europe Awards 2025 for the best law firm in the Czech Republic.
5.3.2025
•
News
First Commentary on the Bonds Act Published
C.H. Beck has released the first-ever commentary on the Bonds Act, authored primarily by KŠB’s Jan Lasák, Jan Dědič, and Josef Kříž. Spanning over 700 pages, this comprehensive publication provides an in-depth interpretation of the Act’s individual provisions, drawing on the authors’ extensive expertise in corporate finance
